$NVCR
NovoCure Ltd Stock $nvcr

$nvcr Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000164511322000067 Filed on July 28, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$131.0M	$140.9M	$137.5M
YoY Change	-1.95%	5.5%	2.12%
Cost Of Revenue	$29.75M	$28.50M	$27.73M
YoY Change	-1.51%	-0.34%	5.09%
Gross Profit	$101.2M	$112.4M	$109.8M
YoY Change	-2.08%	7.1%	1.39%
Gross Profit Margin	77.29%	79.77%	79.84%
Selling, General & Admin	$73.90M	$76.42M	$68.39M
YoY Change	15.82%	14.23%	9.46%
% of Gross Profit	72.99%	68.01%	62.28%
Research & Development	$51.96M	$57.08M	$42.23M
YoY Change	7.92%	13.44%	-8.02%
% of Gross Profit	51.32%	50.8%	38.46%
Depreciation & Amortization	$2.660M	$2.654M	$2.610M
YoY Change	-2.71%	7.02%	10.13%
% of Gross Profit	2.63%	2.36%	2.38%
Operating Expenses	$125.9M	$133.5M	$110.6M
YoY Change	12.42%	13.89%	2.06%
Operating Profit	-$24.61M	-$21.13M	-$806.0K
YoY Change	187.78%	71.84%	815.91%
Interest Expense	$1.194M	-$2.228M	-$1.709M
YoY Change	-160.27%	137.02%	-34.27%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$23.42M	-$23.36M	-$2.515M
YoY Change	122.32%	76.47%	-8.01%
Income Tax	$3.159M	$652.0K	$2.132M
% Of Pretax Income
Net Earnings	-$26.58M	-$24.01M	-$4.647M
YoY Change	102.5%	63.98%	12.57%
Net Earnings / Revenue	-20.29%	-17.04%	-3.38%
Basic Earnings Per Share	-$0.25	-$0.23	-$0.04
Diluted Earnings Per Share	-$0.25	-$0.23	-$0.04
COMMON SHARES
Basic Shares Outstanding	104.7M shares	104.6M shares	104.2M shares
Diluted Shares Outstanding	104.9M shares	104.6M shares	104.2M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$894.5M	$807.7M	$932.3M
YoY Change	-4.21%	-10.16%	7.86%
Cash & Equivalents	$243.8M	$367.0M	$190.7M
Short-Term Investments	$741.4M	$583.0M	$744.1M
Other Short-Term Assets	$76.09M	$141.6M	$889.0K
YoY Change	8799.18%	1135.09%	-92.2%
Inventory	$26.79M	$29.53M	$29.08M
Prepaid Expenses
Receivables	$87.55M	$97.56M	$101.0M
Other Receivables	$17.48M	$18.19M	$17.34M
Total Short-Term Assets	$1.102B	$1.095B	$1.081B
YoY Change	3.12%	4.69%	6.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$29.75M	$26.56M	$25.07M
YoY Change	154.25%	124.01%	113.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.71M	$10.90M	$11.83M
YoY Change	-0.26%	2.52%	9.63%
Total Long-Term Assets	$71.84M	$68.12M	$69.63M
YoY Change	39.64%	32.28%	32.89%
TOTAL ASSETS
Total Short-Term Assets	$1.102B	$1.095B	$1.081B
Total Long-Term Assets	$71.84M	$68.12M	$69.63M
Total Assets	$1.174B	$1.163B	$1.150B
YoY Change	4.8%	5.98%	7.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$77.03M	$79.91M	$69.19M
YoY Change	28.37%	40.72%	31.28%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$141.1M	$135.4M	$127.8M
YoY Change	13.27%	16.52%	15.67%
LONG-TERM LIABILITIES
Long-Term Debt	$564.7M	$563.8M	$563.0M
YoY Change	0.59%	0.59%	0.62%
Other Long-Term Liabilities	$222.0K	$239.0K	$156.0K
YoY Change	-41.42%	38.15%	-11.86%
Total Long-Term Liabilities	$587.7M	$585.6M	$586.5M
YoY Change	0.86%	0.35%	0.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$141.1M	$135.4M	$127.8M
Total Long-Term Liabilities	$587.7M	$585.6M	$586.5M
Total Liabilities	$728.8M	$721.0M	$714.3M
YoY Change	3.04%	3.03%	2.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$741.2M	-$714.6M	-$690.6M
YoY Change	12.39%	10.56%	9.32%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$445.4M	$441.7M	$435.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.174B	$1.163B	$1.150B
YoY Change	4.8%	5.98%	7.73%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$26.58M	-$24.01M	-$4.647M
YoY Change	102.5%	63.98%	12.57%
Depreciation, Depletion And Amortization	$2.660M	$2.654M	$2.610M
YoY Change	-2.71%	7.02%	10.13%
Cash From Operating Activities	$22.42M	$15.76M	-$3.687M
YoY Change	-8.11%	-39.78%	-120.74%
INVESTING ACTIVITIES
Capital Expenditures	$5.703M	$4.131M	$5.093M
YoY Change	72.98%	57.79%	27.93%
Acquisitions
YoY Change
Other Investing Activities	-$144.5M	$159.9M	-$12.32M
YoY Change	-147.24%	7994300.0%	-121.18%
Cash From Investing Activities	-$150.2M	$155.8M	-$17.41M
YoY Change	-149.63%	-6049.47%	-132.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$2.759M	$0.00
YoY Change		16.36%
Debt Paid & Issued, Net	$7.000K	$7.000K	$7.000K
YoY Change	16.67%	0.0%	16.67%
Cash From Financing Activities	$4.204M	$4.736M	$3.141M
YoY Change	38.47%	-57.18%	-60.52%
NET CHANGE
Cash From Operating Activities	$22.42M	$15.76M	-$3.687M
Cash From Investing Activities	-$150.2M	$155.8M	-$17.41M
Cash From Financing Activities	$4.204M	$4.736M	$3.141M
Net Change In Cash	-$123.7M	$176.1M	-$17.98M
YoY Change	-137.48%	408.91%	-122.53%
FREE CASH FLOW
Cash From Operating Activities	$22.42M	$15.76M	-$3.687M
Capital Expenditures	$5.703M	$4.131M	$5.093M
Free Cash Flow	$16.72M	$11.63M	-$8.780M
YoY Change	-20.78%	-50.62%	-163.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001645113
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37565
	dei	Entity Registrant Name EntityRegistrantName	NovoCure Limited
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Y9
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1057807
	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 4 The Forum
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Grenville Street
	dei	Entity Address Country EntityAddressCountry	JE
	dei	Entity Address City Or Town EntityAddressCityOrTown	St. Helier
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	JE2 4UF
	dei	City Area Code CityAreaCode	44 (0) 15
	dei	Local Phone Number LocalPhoneNumber	3475 6700
	dei	Security12b Title Security12bTitle	Ordinary Shares, no par value
	dei	Trading Symbol TradingSymbol	NVCR
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	104738581	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	367014000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	208802000	usd
CY2022Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	581503000	usd
CY2021Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	728898000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	749000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	807000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	97563000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	93567000	usd
CY2022Q2	nvcr	Receivables And Prepaid Expenses ReceivablesAndPrepaidExpenses	18195000	usd
CY2021Q4	nvcr	Receivables And Prepaid Expenses ReceivablesAndPrepaidExpenses	17025000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	29531000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	24427000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1094555000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1073526000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26561000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22693000	usd
CY2022Q2	nvcr	Field Equipment Net Noncurrent FieldEquipmentNetNoncurrent	12377000	usd
CY2021Q4	nvcr	Field Equipment Net Noncurrent FieldEquipmentNetNoncurrent	12923000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18281000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18267000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10898000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12086000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	68117000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	65969000	usd
CY2022Q2	us-gaap	Assets Assets	1162672000	usd
CY2021Q4	us-gaap	Assets Assets	1139495000	usd
CY2022Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	79910000	usd
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	72600000	usd
CY2022Q2	nvcr	Other Accounts Payable Lease Liabilities And Accrued Expenses Current OtherAccountsPayableLeaseLiabilitiesAndAccruedExpensesCurrent	55489000	usd
CY2021Q4	nvcr	Other Accounts Payable Lease Liabilities And Accrued Expenses Current OtherAccountsPayableLeaseLiabilitiesAndAccruedExpensesCurrent	70002000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	135399000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	142602000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	563846000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	562216000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	4541000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	6477000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13377000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12997000	usd
CY2022Q2	nvcr	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	3598000	usd
CY2021Q4	nvcr	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	4543000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	239000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	166000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	585601000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	586399000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	721000000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	729001000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	104727685	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	104727685	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	103971263	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	103971263	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1158348000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1099589000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2095000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3169000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-714581000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-685926000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	441672000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	410494000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1162672000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1139495000	usd
CY2022Q2	us-gaap	Revenues Revenues	140866000	usd
CY2021Q2	us-gaap	Revenues Revenues	133517000	usd
	us-gaap	Revenues Revenues	278413000	usd
	us-gaap	Revenues Revenues	268212000	usd
CY2021	us-gaap	Revenues Revenues	535031000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	28503000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	28599000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	56230000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	54984000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	114877000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	112363000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	104918000	usd
	us-gaap	Gross Profit GrossProfit	222183000	usd
	us-gaap	Gross Profit GrossProfit	213228000	usd
CY2021	us-gaap	Gross Profit GrossProfit	420154000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	57075000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50315000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	99309000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	96231000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	201303000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	44750000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	34138000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	82634000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	65495000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	137057000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31666000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32760000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	62174000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	63885000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	126127000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	133491000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	117213000	usd
	us-gaap	Operating Expenses OperatingExpenses	244117000	usd
	us-gaap	Operating Expenses OperatingExpenses	225611000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	464487000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-21128000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-12295000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21934000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12383000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-44333000	usd
CY2022Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2228000	usd
CY2021Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	940000	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	3937000	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	3586000	usd
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	7742000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23356000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13235000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25871000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15969000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-52075000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	652000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1406000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2784000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2800000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6276000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-24008000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14641000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28655000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18769000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-58351000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104627789	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103484866	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104408164	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103061557	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103433274	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104627789	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103484866	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104408164	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103061557	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103433274	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-24008000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14641000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28655000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18769000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-58351000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	680000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	413000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1010000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	145000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	302000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-769000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-769000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	678000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-416000	usd
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-833000	usd
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-2568000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-361000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24775000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13812000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27581000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16056000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-57688000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	410494000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25045000	usd
CY2022Q1	nvcr	Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures	3148000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1841000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4647000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	435881000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25823000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2759000	usd
CY2022Q2	nvcr	Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures	1984000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-767000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-24008000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	441672000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	476526000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18863000	usd
CY2021Q1	nvcr	Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures	7961000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1884000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-4128000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	372134000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27881000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2371000	usd
CY2021Q2	nvcr	Stock Issued During Period Value Stock Options And Warrants Exercised And Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercisedAndRestrictedStockAwardForfeitures	8695000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	829000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14641000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	397269000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-24008000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14641000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28655000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18769000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-58351000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2654000	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2480000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5264000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4850000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10251000	usd
CY2022Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-602000	usd
CY2021Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	0	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-823000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	0	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-94000	usd
CY2022Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	216000	usd
CY2021Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	178000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	351000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	354000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	649000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	25823000	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	27881000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	50868000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	46744000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	94900000	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-943000	usd
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-372000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1192000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2529000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3231000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2257000	usd
CY2021Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3026000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5204000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7649000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5270000	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	827000	usd
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	925000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1511000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1528000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3101000	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	209000	usd
CY2021Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1663000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5013000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-367000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2483000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-2356000	usd
CY2021Q2	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1584000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-4219000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-4519000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-3016000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7649000	usd
CY2021Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5122000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7160000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2496000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	27777000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2144000	usd
CY2021Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2418000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4475000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-6812000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-10980000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15762000	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26172000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12075000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	43952000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	82756000	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4131000	usd
CY2021Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2618000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9224000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6599000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24170000	usd
CY2022Q2	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	437034000	usd
CY2021Q2	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	0	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	716034000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	608000000	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	958000000	usd
CY2022Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	277146000	usd
CY2021Q2	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	568463000	usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	549848000	usd
CY2021	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	1078664000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	155757000	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2618000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	138347000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	51553000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-144834000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2759000	usd
CY2021Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2371000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2759000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2371000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4546000	usd
CY2022Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7000	usd
CY2021Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	14000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	13000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	26000	usd
CY2022Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1984000	usd
CY2021Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8695000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5132000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	16656000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	21182000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4736000	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11059000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7877000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19014000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25702000	usd
CY2022Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-120000	usd
CY2021Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-145000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-105000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-188000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	176135000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34610000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	158154000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	114414000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-36564000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191628000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	325977000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	209609000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246173000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246173000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367763000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	360587000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367763000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	360587000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	209609000	usd
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1854000	usd
CY2021Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2490000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3027000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	85000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3110000	usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
CY2021Q2	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	101000	usd
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	279000	usd
CY2021Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	665000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3859000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	949000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5387000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	147900000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	11000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	780000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	147131000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	147131000	usd
CY2022Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	89945000	usd
CY2022Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	usd
CY2022Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	213000	usd
CY2022Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	89732000	usd
CY2022Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	89945000	usd
CY2022Q2	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Amortized Cost CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesAmortizedCost	949286000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain	11000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss	993000	usd
CY2022Q2	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Fair Value CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesFairValue	948304000	usd
CY2022Q2	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecurities	948517000	usd
CY2021Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	304804000	usd
CY2021Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	8000	usd
CY2021Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	0	usd
CY2021Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	304812000	usd
CY2021Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	304804000	usd
CY2021Q4	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Amortized Cost CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesAmortizedCost	937700000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain	8000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss	0	usd
CY2021Q4	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Fair Value CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesFairValue	937708000	usd
CY2021Q4	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecurities	937700000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	140555000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	780000	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2545000	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1485000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11573000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8274000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15413000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	14668000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	29531000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	24427000	usd
CY2022Q2	us-gaap	Deposits Assets DepositsAssets	2319000	usd
CY2021Q4	us-gaap	Deposits Assets DepositsAssets	2350000	usd
CY2022Q2	us-gaap	Contractual Obligation ContractualObligation	2642000	usd
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	2698000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8549322	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	33.09
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	665007	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	80.67
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	269961	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	18.78
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	68591	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	79.17
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8875777	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	36.74
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7189164	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	24.86
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	269961	shares
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25823000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27881000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	50868000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	46744000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	94900000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-24008000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14641000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28655000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18769000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-58351000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104627789	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103484866	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104408164	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103061557	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103433274	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104627789	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103484866	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104408164	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103061557	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103433274	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7746398	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9098788	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7790467	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9363037	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8524922	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	38938000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	35616000	usd
CY2022Q2	us-gaap	Revenues Revenues	140866000	usd
CY2021Q2	us-gaap	Revenues Revenues	133517000	usd
	us-gaap	Revenues Revenues	278413000	usd
	us-gaap	Revenues Revenues	268212000	usd
CY2021	us-gaap	Revenues Revenues	535031000	usd

Files In Submission

Name	View Source	Status
0001645113-22-000067-index-headers.html	Edgar Link	pending
0001645113-22-000067-index.html	Edgar Link	pending
0001645113-22-000067.txt	Edgar Link	pending
0001645113-22-000067-xbrl.zip	Edgar Link	pending
exhibit102-nonxemployeedir.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvcr-20220630.htm	Edgar Link	pending
nvcr-20220630.xsd	Edgar Link	pending
nvcr-20220630exx311.htm	Edgar Link	pending
nvcr-20220630xexx312.htm	Edgar Link	pending
nvcr-20220630xexx321.htm	Edgar Link	pending
nvcr-20220630xexx322.htm	Edgar Link	pending
nvcr-20220630_cal.xml	Edgar Link	unprocessable
nvcr-20220630_def.xml	Edgar Link	unprocessable
nvcr-20220630_g1.jpg	Edgar Link	pending
nvcr-20220630_htm.xml	Edgar Link	completed
nvcr-20220630_lab.xml	Edgar Link	unprocessable
nvcr-20220630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVCR
NovoCure Ltd Stock $nvcr

2022 Q3 Form 10-Q Financial Statement

#000164511322000067 Filed on July 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVCR NovoCure Ltd Stock $nvcr

2022 Q3 Form 10-Q Financial Statement

#000164511322000067 Filed on July 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVCR
NovoCure Ltd Stock $nvcr